4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001053369-14-000019
$ELTPCIK 0001053369operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:18 PM ET
Size
5.1 KB
Accession
0001053369-14-000019
Insider Transaction Report
Form 4
Ward Carter Julian
Chief Financial Officer
Transactions
- Award
Common Stock
2014-02-25$0.09/sh+330,159$30,011→ 875,582 total
Holdings
- 1,355,014(indirect: By IRA)
Common Stock
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:18 PM ET
- Size
- 5.1 KB